LPT
Legacy Private Trust Portfolio holdings
AUM
$1.55B
1-Year Return
14.77%
This Quarter Return
+2.14%
1 Year Return
+14.77%
3 Year Return
+56.77%
5 Year Return
+80.65%
10 Year Return
+163%
AUM
$663M
AUM Growth
+$5.13M
(+0.78%)
Cap. Flow
-$2.69M
Cap. Flow
% of AUM
-0.41%
Top 10 Holdings %
Top 10 Hldgs %
32.94%
Holding
255
New
18
Increased
78
Reduced
110
Closed
19
Top Buys
| 1 |
Vanguard Long-Term Bond ETF
BLV
|
$3.88M |
| 2 |
NLSN
Nielsen Holdings plc
NLSN
|
$3.82M |
| 3 |
Industrial Select Sector SPDR Fund
XLI
|
$3.4M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
$3.39M |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
$3.25M |
Top Sells
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
$4.51M |
| 2 |
Vanguard Growth ETF
VUG
|
$4.48M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
$4.37M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
$3.88M |
| 5 |
Vanguard Value ETF
VTV
|
$3.33M |
Sector Composition
| 1 | Consumer Staples | 10.61% |
| 2 | Financials | 9.79% |
| 3 | Healthcare | 6.87% |
| 4 | Technology | 5.75% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Tyson Foods
TSN
$20B
| $1.08M | 0.16% |
16,160
+4,130
| +34% | +$275K |
|
127
Biogen
BIIB
$20.5B
| $1.07M | 0.16% |
4,100
+160
| +4% | +$41.6K |
|
128
Oracle
ORCL
$626B
| $1.04M | 0.16% |
25,531
+160
| +0.6% | +$6.54K |
|
129
Best Buy
BBY
$16.3B
| $1.04M | 0.16% |
32,130
+12,040
| +60% | +$390K |
|
130
iShares MSCI EAFE ETF
EFA
$65.9B
| $1.03M | 0.16% |
+18,000
| New | +$1.03M |
|
131
Philip Morris
PM
$251B
| $1.02M | 0.15% |
10,340
+35
| +0.3% | +$3.44K |
|
132
Thermo Fisher Scientific
TMO
$185B
| $1.01M | 0.15% |
7,143
+1,563
| +28% | +$221K |
|
|
IBMG
133
DELISTED
iShares iBonds Sep 2018 Term Muni Bond ETF
IBMG
| $1.01M | 0.15% |
39,450
+16,000
| +68% | +$410K |
|
134
Coca-Cola
KO
$294B
| $976K | 0.15% |
21,020
-2,100
| -9% | -$97.5K |
|
135
SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.44B
| $970K | 0.15% |
19,865
-9,619
| -33% | -$470K |
|
136
Avanos Medical
AVNS
$587M
| $961K | 0.14% |
33,473
-18
| -0.1% | -$517 |
|
137
Everest Group
EG
$14.5B
| $951K | 0.14% |
4,815
| – | – |
|
138
Berkshire Hathaway Class B
BRK.B
$1.09T
| $950K | 0.14% |
6,695
-913
| -12% | -$130K |
|
139
PepsiCo
PEP
$201B
| $910K | 0.14% |
8,878
-1,993
| -18% | -$204K |
|
140
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.1B
| $907K | 0.14% |
25,645
-4,440
| -15% | -$157K |
|
141
Northrop Grumman
NOC
$83B
| $893K | 0.13% |
+4,510
| New | +$893K |
|
142
Phillips 66
PSX
$53.2B
| $888K | 0.13% |
10,254
| – | – |
|
143
Procter & Gamble
PG
$373B
| $878K | 0.13% |
10,667
-234
| -2% | -$19.3K |
|
144
Eli Lilly
LLY
$666B
| $870K | 0.13% |
12,082
-2,460
| -17% | -$177K |
|
145
Keurig Dr Pepper
KDP
$39.7B
| $823K | 0.12% |
9,200
-170
| -2% | -$15.2K |
|
146
Walmart
WMT
$805B
| $818K | 0.12% |
35,841
+9,540
| +36% | +$218K |
|
147
Cigna
CI
$81.2B
| $808K | 0.12% |
5,885
+1,730
| +42% | +$238K |
|
148
SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$10.7B
| $804K | 0.12% |
23,450
| – | – |
|
149
Henry Schein
HSIC
$8.22B
| $798K | 0.12% |
+11,781
| New | +$798K |
|
150
3M
MMM
$82.8B
| $797K | 0.12% |
5,717
| – | – |
|